Postoperative Analgesia After Shoulder Replacement

Completed

Conditions studied: Analgesia

In brief

A comparison was made regarding opioid analgesic usage immediately after elective shoulder replacement and for seven days at home between patients randomly given either 0.5% or 0.75% ropivacaine via interscalene block prior to surgery. It is hypothesized that no significant difference will exist between both groups with respect to pain medication used in the hospital and for a 7-day period at home.

Key facts

Study ID

NCT01003860

Run by

Thomas Jefferson University

People needed

39

Starts

2006-06-01

Expected to finish

2007-04-01

Last updated by the study team

2009-10-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• patients undergoing total shoulder replacement surgery
• 18 years of age or older
• expected length of stay of at least 24 hours
• able to report pain levels
• able to request medications as needed
• American Society of Anesthesiologist (ASA) physical status classification of P1 or P2

You may not qualify if…

• liver disease
• kidney disease
• antidepressant therapy (e.g., for clinical depression and/ or chronic pain syndrome)
• ASA physical status classification of P3 or higher
• pregnancy
• allergy to any medications used to treat patient

Where it is running

• Methodist Hospital — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.